Interim report
Page 1
HERANTIS PHARMA Plc Half Year Report 2026 January - June 2026 HERANTIS PHARMA Half Year Report January 1 - June 30 , 2026 Billa Herantis Pharma Plc is a clinical - stage biotechnology company developing disease- modifying therapies for Parkinson's disease pg . 1